+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 40Years
All Genders
Healthy Volunteers
ID05877560

Testing Non-invasive Brain Stimulation to Improve or Shorten Therapy for Adults with Symptomatic Convergence Insufficiency

Led by Midwestern University · Updated on 2024-12-02

150

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying adults aged 18 to 40 with symptomatic convergence insufficiency to evaluate the effectiveness of non-invasive brain stimulation compared to traditional office-based vergenceaccommodative therapy. The trial aims to find out if brain stimulation can shorten therapy time from 12 weeks to 8 weeks, and whether brain stimulation alone is as effective as the therapy in improving symptoms. Participants will be assigned randomly to one of three groups to compare treatment effects. The study involves three groups one receives 8 sessions of non-invasive brain stimulation combined with 8 weeks of office-based vergenceaccommodative therapy another receives 8 sessions of sham placebo stimulation with 8 weeks of the therapy and the third group receives 8 sessions of brain stimulation only. Brain stimulation is delivered using an anodal transcranial direct current device applying a 2 milliamp current over the left frontal eye field for about 20 minutes per session. Therapy includes weekly 60-minute in-office sessions and prescribed daily home exercises. Participants will be monitored through near point of convergence NPC and positive fusional vergence PFV measurements at 4, 6, and 8 weeks during treatment, and again at 6 and 12 months after treatment ends. Symptom surveys will also be collected at 8 weeks and during follow-up. The study includes informed consent, baseline vision assessments, and safety monitoring throughout the trial, which is sponsored by Midwestern University and runs until 2028.

CONDITIONS

Brief Title

Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency

Research Team

A

Arijit Chakraborty, PhD

A

Adrienne C Quan, OD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here